3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Glioma
13
Astrocytoma
9
Brain Neoplasms
8
Neuroblastoma
6
Neoplasms
6
Gliosarcoma
6
Sarcoma, Ewing
4
Medulloblastoma
4
Rhabdomyosarcoma
3
Recurrence
3
Oligodendroglioma
3
Diffuse Intrinsic Pontine Glioma
3
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
Specimen Handling
3
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Biopsy
2
talimogene laherparepvec
1
peposertib
1
liposomal doxorubicin
1
fludarabine
1
aldesleukin
1
X-Rays
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Ipilimumab
1
Histamine H2 Antagonists
1
Famotidine
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Temozolomide
×
30 days
×
Clear all
No trials found.